These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1899432)

  • 1. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
    Pritchett EL; DaTorre SD; Platt ML; McCarville SE; Hougham AJ
    J Am Coll Cardiol; 1991 Feb; 17(2):297-303. PubMed ID: 1899432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.
    Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Bhandari AK; Hawkinson RW; Pritchett EL
    Circulation; 1989 Dec; 80(6):1557-70. PubMed ID: 2513143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.
    Bhandari AK; Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Cullen MT; Hawkinson RW; Pritchett EL
    Am Heart J; 1992 Aug; 124(2):381-6. PubMed ID: 1636582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
    Garre L; Alvarez A; Cianciulli T; Quiroga J; Califano J; Mautner B
    Arch Inst Cardiol Mex; 1989; 59(3):241-4. PubMed ID: 2506843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group.
    Anderson JL; Platt ML; Guarnieri T; Fox TL; Maser MJ; Pritchett EL
    Am J Cardiol; 1994 Sep; 74(6):578-84. PubMed ID: 8074041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
    Nathan AW; Camm AJ; Bexton RS; Hellestrand KJ
    Clin Cardiol; 1987 May; 10(5):317-22. PubMed ID: 3109795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators.
    Anderson JL
    Am J Cardiol; 1992 Aug; 70(5):11A-17A; discussion 17A-18A. PubMed ID: 1509993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ
    Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
    Hohnloser SH; Zabel M
    Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials of flecainide acetate in the management of supraventricular arrhythmias.
    Camm AJ; Bashir Y
    Cardiologia; 1990 Mar; 35(3):193-7. PubMed ID: 2123129
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
    Aliot E; Denjoy I
    Am J Cardiol; 1996 Jan; 77(3):66A-71A. PubMed ID: 8607394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.
    Henthorn RW; Waldo AL; Anderson JL; Gilbert EM; Alpert BL; Bhandari AK; Hawkinson RW; Pritchett EL
    Circulation; 1991 Jan; 83(1):119-25. PubMed ID: 1898640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic treatment with flecainide (Tambocor). Clinical experience from 107 patients.
    Frandsen F; Pless P; Mickley H; Møller M
    Acta Cardiol; 1990; 45(5):351-7. PubMed ID: 1704167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
    Dorian P; Naccarelli GV; Coumel P; Hohnloser SH; Maser MJ
    Am J Cardiol; 1996 Jan; 77(3):89A-95A. PubMed ID: 8607397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flecainide for supraventricular tachyarrhythmias.
    Med Lett Drugs Ther; 1992 Jul; 34(875):71-2. PubMed ID: 1630411
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of flecainide acetate in the treatment of supraventricular tachyarrhythmias.
    Marwick TH; Woodhouse SP
    Am J Cardiol; 1988 Jul; 62(1):171. PubMed ID: 3132846
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response.
    Page RL; Connolly SJ; Wilkinson WE; Marcello SR; Schnell DJ; Pritchett EL;
    Am Heart J; 2002 Apr; 143(4):643-9. PubMed ID: 11923801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.